Hook & thesis
Elbit Systems' pause in the $770s is an opportunity, not an indictment. The shares have come off recent highs but the company's backbone - a $28.1 billion order backlog and multi-year contracts including a $1.4 billion European modernization award - remains intact. With revenue of $7.94 billion in 2025, improved margins and a local-scale credit upgrade, the pullback is a tactical buy for disciplined traders who can tolerate defense sector volatility.
We are recommending a long swing trade into strength: enter near $770, place a protective stop at $720 and scale toward $950 as the primary target, with a longer-term stretch target toward prior highs if backlog conversion and margin trajectory continue. This trade offers asymmetric upside versus a defined downside and is supported by improving fundamentals and macro tailwinds in unmanned systems, EO/IR, and electronic warfare.
What the company does and why the market should care
Elbit Systems Ltd is a diversified defense electronics contractor based in Haifa, Israel. The company develops and supplies airborne, land and naval systems, plus training and sustainment services. Its offerings span autonomous systems, electronic warfare, precision-guided munitions and integrated avionics - product lines that are in higher demand amid sustained defense modernization globally.
The market cares because Elbit sits at the intersection of secular defense spending and near-term modernization cycles in Europe and Asia. Recent data points that matter:
- Revenue of $7.94 billion in 2025 - a material revenue base that supports larger multi-year programs.
- A record order backlog of $28.1 billion, which provides revenue visibility and de-risks top-line growth over several years.
- A $1.4 billion European contract announced in May covering autonomous systems, electronic warfare and precision munitions - multi-year work that should feed backlog conversion.
- S&P Maalot upgraded the long-term rating to ilAAA with a stable outlook on 05/20/2026, reflecting stronger operating performance and financial ratios.
Support from the market and technicals
Shares trade at $776 today, off the 52-week high of $1,016.06 and well above the 52-week low of $432.85. Short-term technicals show consolidation rather than breakdown: the 10-day simple moving average is $824.56, the 20-day SMA is $801.97 and the 50-day SMA is $797.85. Momentum indicators are neutral–slightly constructive: the RSI sits at 43.95 and the MACD histogram is positive, signaling bullish momentum building beneath the surface.
Short interest has ticked up in recent reporting windows (most recently 249,525 shares settled on 07/31/2026) but days-to-cover remain modest (about 3.3), limiting the risk of a dramatic squeeze-driven reversal.
Valuation framing
At a market cap of roughly $37.73 billion and trailing P/E about 67.2, Elbit trades at a premium to many industrial defense names on a pure earnings basis. Price-to-book sits near 9.07. The high multiple reflects (1) strong backlog-driven revenue visibility, (2) attractive margins relative to peers in certain product lines, and (3) a defensible technology position in autonomous and EW systems.
That said, the premium requires execution: backlog must convert at expected margins and geopolitical-driven contract timing can create lumpiness. For a trader, the current pullback reduces immediate valuation risk versus recent highs and creates an entry where upside to the 52-week range is meaningful while downside is limited by a clear stop.
| Metric | Value |
|---|---|
| Current price | $776.00 |
| Market cap | $37.73B |
| Revenue (2025) | $7.94B |
| Order backlog | $28.1B |
| P/E | 67.2 |
| 52-week range | $432.85 - $1,016.06 |
| Dividend | $1.00 per share, quarterly (yield ~0.4%) |
Catalysts to watch (2-5)
- Backlog conversion cadence - quarterly results that show pace of backlog conversion into revenue and margins will determine whether valuation expansion is sustainable.
- Further contract wins, especially in Europe and India - additional multi-year awards would add to visibility and could re-rate the stock.
- Margin expansion - improved operating margins from higher mix of software, sustainment and pricier autonomous systems would justify higher multiples.
- Macro/geopolitical events - defense budgets and modernization cycles are major drivers; positive geopolitical developments in NATO/EU markets tend to be supportive.
Trade plan (actionable)
We recommend a directional long trade with defined risk parameters. Exact orders:
- Entry: $770.00
- Stop-loss: $720.00
- Primary target: $950.00
Horizon guidance:
- Short term (10 trading days): look for a bounce toward $840 as the first liquidity test and intraday technical recovery.
- Mid term (45 trading days): primary target $950; this assumes steady backlog conversion and no large negative news flow on program timing.
- Long term (180 trading days): if backlog conversion accelerates or new large contracts are announced, a move toward prior highs near $1,000+ is realistic.
Rationale: entry at $770 buys the pullback below recent short-term averages but above a technical level that, if violated, would indicate deeper weakness. Stop at $720 limits downside to a known tolerance while giving the trade room to breathe through intraday noise. Targets reflect a reversion toward recent resistance and a re-rating if fundamentals continue to improve.
Risks and counterarguments
No trade is without risk. Key downside scenarios:
- Program delays or cancellations: Defense contracts are exposed to political and budgetary shifts. If major programs slip or are cancelled, reported revenue and backlog conversion could disappoint and the stock could revisit lower levels.
- Valuation compression: The current P/E (~67) and P/B (~9) already embed high expectations. If growth slows or margins compress, multiple contraction could lead to outsized downside.
- Geopolitical volatility: While geopolitics can be a tailwind, it can also create spikes in supply chain disruption or offsetting diplomatic actions that delay procurement and delivery.
- Execution on margin expansion: If Elbit cannot sustain margin improvements reported recently, investors may re-price the stock back down quickly.
- Market structure risk: A rise in short activity or a rapid risk-off across global equities could exaggerate moves beyond fundamentals. Short interest has increased in recent periods.
Counterargument: A reasonable opposing view is that the market has already priced in most of Elbit's backlog and the premium multiple reflects sustained, above-market margin expectations. If the company converts backlog at lower-than-expected margins or if the timing of contract awards is slower, upside could be limited while downside risk remains due to multiple compression. That view argues for waiting for clearer proof of margin durability before buying.
Conclusion - what would change my mind
On balance, I favor a tactical long into this pullback. The $28.1 billion backlog, $1.4 billion recent contract, and a solid revenue base of $7.94 billion provide a visible earnings runway that supports the trade. The entry at $770 with a $720 stop makes the risk-reward attractive for a swing trade toward $950 over a 45-trading-day horizon.
What would change my mind: a string of earnings or backlog-conversion misses, a sharp downgrade from a major ratings agency, or a material change in program timelines that cuts into multi-year revenue visibility would push me to exit or reverse. Conversely, fresh multi-billion-dollar awards or demonstrable margin expansion on reported quarters would justify adding to the position and extending the target toward prior highs.
Key takeaways
- Elbit's record backlog and recent large contract give the stock durable revenue visibility.
- The current pullback offers an entry with defined downside and meaningful upside to recent resistance levels.
- Use strict risk management: entry $770, stop $720, primary target $950; monitor backlog conversion and margin trends closely.
Trade plan: Enter $770.00, stop $720.00, target $950.00. Horizon: primary mid-term swing (45 trading days) with tactical checks at 10 and 180 trading days.